
Phyllodes Tumor of the Breast: A Fast-Growing Lump, How It Differs from Fibroadenoma, and Treatment
A phyllodes tumor is an uncommon (under 1% of breast tumors) tumor of the breast connective tissue, most often in women aged 40–50. Its hallmark is a fast-growing lump that can reach several centimeters within months. It is classified as benign, borderline or malignant, and most are benign. The main treatment is surgical removal of the whole tumor; lymph node surgery is not needed. At Namarak Hospital, breast surgeons plan surgery to achieve margins appropriate to the tumor type, using oncoplastic techniques to preserve breast shape.
How does phyllodes differ from fibroadenoma?
Both are fibroepithelial tumors; ultrasound and needle biopsy may not reliably tell them apart
Fibroadenoma usually occurs in younger women, is small, and grows slowly or stays stable — see Fibroadenoma
Phyllodes occurs at older ages, is often larger than 3 cm, grows quickly, and may contain clefts or cystic spaces
A presumed fibroadenoma that grows unusually fast should be re-evaluated to exclude phyllodes
Diagnosis
Clinical exam, 3D mammography and ultrasound
Core needle biopsy — may report a fibroepithelial lesion that cannot be fully classified; the final diagnosis often comes from complete excision — see Breast biopsy
For malignant tumors, lung imaging may be added, as spread occurs through the bloodstream rather than lymph nodes
Treatment
Surgery
Benign — excise the whole tumor; current NCCN guidance states wide margins are not required, and re-excision is usually unnecessary for close margins with no residual tumor
Borderline / malignant — wide excision aiming for margins of about 1 cm, usually with breast-conserving surgery and oncoplastic techniques; very large tumors relative to breast size may need mastectomy with consideration of reconstruction
No axillary lymph node surgery, as phyllodes rarely spreads to lymph nodes
Additional treatment
Radiation — may be considered for malignant tumors after breast-conserving surgery or for recurrences, to reduce local recurrence
Endocrine therapy — not effective
Chemotherapy — not routine; used only for metastatic malignant tumors, following soft-tissue sarcoma principles
Recurrence and follow-up
Local recurrence occurs in about 10–20% depending on type, usually within the first 2–3 years
Follow-up with exam and ultrasound every 6 months for 2–3 years, then yearly
Most recurrences can be treated with further surgery
Frequently asked questions (FAQ)
Is a phyllodes tumor cancer?
Most are benign; only a minority are borderline or malignant. All are treated mainly by surgical removal.
How is it different from a fibroadenoma?
Phyllodes tumors occur at older ages and are larger and faster-growing, while fibroadenomas are usually small and slow-growing. Needle biopsy may not distinguish them; the final diagnosis often comes from surgery.
Will I need a mastectomy?
Usually not. Most can be removed with breast-conserving surgery and oncoplastic techniques, unless the tumor is very large relative to the breast.
Do I need lymph node surgery or chemotherapy?
No lymph node surgery is needed because phyllodes rarely spreads to lymph nodes, and chemotherapy or endocrine therapy is not used routinely.
Can it come back after surgery?
About 10–20% recur, usually in the first 2–3 years, so regular ultrasound follow-up is important. Most recurrences can be removed again.
About Namarak Hospital
Namarak Hospital is a specialized breast and breast cancer hospital in Bangkok, providing complete care in one place — from diagnosis with 3D mammography, ultrasound, automated breast ultrasound (ABUS) and biopsy to comprehensive breast cancer treatment, including breast-conserving and reconstructive surgery, intraoperative radiotherapy (IORT), chemotherapy, targeted therapy and endocrine therapy, planned by a multidisciplinary team according to the latest international guidelines. See Breast cancer treatment: a complete guide, contact us on LINE, tel. +66 2 059 0245, or our Second Opinion service.
Related articles
References
Tan PH, et al. Phyllodes tumours of the breast: a consensus review. Histopathology 2016;68:5–21
WHO Classification of Tumours Editorial Board. Breast Tumours. 5th ed. Lyon: IARC; 2019
Rosenberger LH, et al. Contemporary multi-institutional cohort of 550 cases of phyllodes tumors in 2007–2017 demonstrates a need for more individualized margin guidelines. J Clin Oncol 2021;39:178–89
NCCN Clinical Practice Guidelines in Oncology: Breast Cancer (Phyllodes Tumor), Version 4.2026
Medically reviewed by: Namarak Hospital medical team · Last checked: 17 November 2026 · This information is for general education and is not individual medical advice. Please consult your doctor for diagnosis and treatment suited to you.





Comments